Business Wire India Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the…
Read MoreBusiness Micro
News Stories
Omdia: US PC Market Returned to 3% Growth in Q4 2025 as Windows 11 Refresh and Component Cost Increases Converged
Business Wire India The latest research from Omdia shows that US PC shipments (excluding tablets) grew 3% year-on-year in Q4…
Read MoreMirae Asset Sharekhan Sets out Vision to Strengthen India’s Investor Decision-Making Through a Unified Digital Research Centre
Business Wire India Mirae Asset Sharekhan announced the launch of the Mirae Asset India Research Centre, a unified digital research…
Read MoreThe Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping
Business Wire India The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model…
Read MoreViatris Named a Great Place To Work in India for the Fifth Consecutive Year
Business Wire India Mylan Laboratories Limited (a Viatris Company) has been Certified™ by Great Place To Work® in India for…
Read MoreFPT Wins AI & Machine Learning Innovation Award at 2026 InsurInnovator Connect Asia Awards
Business Wire India Global IT services provider FPT has been named a winner of the AI & Machine Learning Innovation…
Read MoreBureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations
Business Wire India Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government…
Read MorePhilip Morris India Certified as a Great Place to Work for the Fifth Consecutive Year
Business Wire India Philip Morris India Trading Private Limited (Formerly IPM India Wholesale Trading Private Limited) (PM India) has been…
Read MoreTakeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
Business Wire India About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week…
Read MoreAAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis
Business Wire India Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions…
Read More